Integrated Biopharma Inc (INBP): Shareholders' Equity
$17.67M
As of 2026-06-30
-2.2%
3-year compound annual growth
+4.3%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $17.67M | -13.0% | 2026-09-25, Balance as of period end |
| 2025-06-30 | $20.32M | +5.6% | 2026-09-25, Balance as of period end |
| 2024-06-30 | $19.24M | +2.0% | 2025-09-23, Balance as of period end |
| 2023-06-30 | $18.86M | +1.5% | 2024-09-20, Balance as of period end |
| 2022-06-30 | $18.57M | +29.6% | 2023-09-15, Balance as of period end |
| 2021-06-30 | $14.33M | +136.3% | 2022-09-13, Balance as of period end |
| 2020-06-30 | $6.07M | +220.5% | 2021-09-02, Balance as of period end |
| 2019-06-30 | $1.89M | n/m | 2020-09-23, Balance as of period end |
| 2018-06-30 | -$5.24M | n/m | 2019-08-29, Balance as of period end |
| 2017-06-30 | -$5.93M | n/m | 2018-09-12, Balance as of period end |
| 2016-06-30 | -$8.33M | n/m | 2017-09-01, Balance as of period end |
| 2015-06-30 | -$9.32M | n/m | 2016-09-02, Balance as of period end |
| 2014-06-30 | -$10.15M | n/m | 2015-09-04, Balance as of period end |
| 2013-06-30 | -$10.29M | n/m | 2014-09-08, Balance as of period end |
| 2012-06-30 | -$10.38M | n/m | 2013-09-30, Balance as of period end |
| 2011-06-30 | -$7.70M | n/a | 2012-10-15, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Integrated Biopharma Inc (INBP) | 2026-06-30 | $17.67M | -13.0% |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | $35.27M | +100.4% |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $24.88M | +8.9% |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | -$33.66M | n/m |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | $518.36M | +147.4% |
| Septerna, Inc. (SEPN) | 2025-12-31 | $381.93M | -9.1% |
| Protagonist Therapeutics, Inc (PTGX) | 2025-12-31 | $614.71M | -9.0% |
| Biofrontera Inc. (BFRI) | 2025-12-31 | $10.48M | +136.4% |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | -$122.76M | n/m |
Compare INBP, XLO, CPIX, AQST side by side · Screen every company in Pharmaceutical Preparations ↗